GlaxoSmithKline Stock News

GlaxoSmithKline plc (LON:GSK) announced a dividend on Wednesday, October 27th, Upcoming.Co.Uk reports. Stockholders of record on Thursday, November 18th will be paid a dividend of GBX 19 ($0.25) per share on Thursday, January 13th. This represents a dividend yield of 1.32%. The ex-dividend date of this dividend is Thursday, November 18th. The official announcement can []

The sexually transmitted diseases (STDs) denotes to a varied clinical syndromes and infections initiated by pathogens that can be developed and spread through sexual activity. The STDs are detected through various tests such as physical examination or assays, rapid plasma

Hyperhidrosis is a disorder that results in excessive sweating of palms, soles, or underarms. Palmer hyperhidrosis is excessive and uncontrollable hand sweating and is the most common type of hyperhidrosis. The sweating may range from mild to severe. Market Snapshot

Market Snapshot A recently published report by QY Research, titled Global Systemic Lupus Erythematosus Treatment Market Size, Status and Forecast 2022 gives an overview of the overall Systemic Lupus Erythematosus Treatment market. This section sheds light on key impact-rendering drivers

Market Snapshot A recently published report by QY Research, titled Global Atherosclerosis Drugs Market Size, Status and Forecast 2022 gives an overview of the overall Atherosclerosis Drugs market. This section sheds light on key impact-rendering drivers and constraints that are

This Gamma-Aminobutyric Acid (GABA) Receptor market report is based on data collected from industry professionals and market analysts across the entire chain. The end-user industry analysis depicted here assists key stakeholders in making critical decisions. The worldwide market is segmented

Analysts expect GlaxoSmithKline plc (NYSE:GSK) to report $12.70 billion in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for GlaxoSmithKlines earnings, with the lowest sales estimate coming in at $12.55 billion and the highest estimate coming in at $12.85 billion. GlaxoSmithKline reported sales of $11.54 billion during the same []

Complete study of the global Skin Disease Treatment market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of

Data Bridge Market Research analyses that the gene therapy products market will exhibit a CAGR of around 22.15% for the forecast period of 2021-2028. Increasing prevalence of cancer and other life threatening diseases globally, rising expenditure for research and development

Respiratory disease vaccine market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5.70% in the above mentioned forecast period. The

Nasal Polyps Diagnosis and Treatment Market Scenario 2020-2027: The Global Nasal Polyps Diagnosis and Treatment market exhibits comprehensive information that is a valuable source of insightful data for business strategists during the decade 2014-2027. On the basis of historical data, Nasal Polyps Diagnosis and Treatment market report provides key segments and their sub-segments, revenue and []

BDO Wealth Advisors LLC grew its holdings in GlaxoSmithKline plc (NYSE:GSK) by 17.1% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 2,739 shares of the pharmaceutical companys stock after buying an additional 400 shares during the quarter. BDO Wealth Advisors LLCs holdings in GlaxoSmithKline []